Related Experiment Videos
Quinone reductases multitasking in the metabolic world
1Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA. David.Ross@uchsc.edu
Drug Metabolism Reviews
|November 24, 2004
Summary
NAD(P)H:quinone oxidoreductase 1 (NQO1) is a multifunctional enzyme involved in cellular defense, antioxidant production, and p53 stabilization. Its role in cancer therapy and the impact of genetic variations are crucial considerations.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- NAD(P)H:quinone oxidoreductase 1 (NQO1), also known as DT-diaphorase, is a key enzyme in cellular redox homeostasis.
- NQO1 detoxifies xenobiotic quinones and reduces endogenous quinones to their antioxidant forms.
- Recent findings suggest NQO1's involvement in superoxide scavenging and p53 stabilization.
Purpose of the Study:
- To review the diverse cellular functions of NQO1.
- To explore NQO1's role in chemoprotection and antioxidant defense.
- To summarize NQO1's involvement in p53-dependent stress responses and its therapeutic potential.
Main Methods:
- Literature review of NQO1 functions.
- Analysis of NQO1's role in cellular defense mechanisms.
- Summary of NQO1's interaction with superoxide and p53.
Main Results:
- NQO1 exhibits chemoprotective activity against electrophilic quinones.
- NQO1 generates antioxidant forms of vitamin E quinone and ubiquinone.
- NQO1 contributes to p53 stabilization and stress responses.
- NQO1 is a target for developing antitumor agents like RH1 and Hsp90 inhibitors.
Conclusions:
- NQO1 possesses multiple essential cellular functions, including detoxification, antioxidant generation, and roles in stress response pathways.
- NQO1's enzymatic activity and polymorphisms significantly impact its chemoprotective effects and therapeutic applications, particularly in cancer treatment.
- Understanding NQO1's multifaceted roles and genetic variations is critical for optimizing NQO1-directed cancer therapies.